Featured Research

from universities, journals, and other organizations

Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered

Date:
April 24, 2014
Source:
Helsingin yliopisto (University of Helsinki)
Summary:
The first Tamiflu resistant pandemic influenza pH1N1 viruses have emerged in Finland. Researchers have identified a novel antiviral agent, and have shown that the pH1N1 viruses are not able to develop resistance against it. Infections with influenza pH1N1 virus vary from asymptomatic to serious complicated illnesses. World Health Organization has recommended Tamiflu for treatment of patients with severe or progressive illness. The disadvantage of this drug is that it targets viral proteins which mutate quickly and the virus develops resistance to it.

Researchers at the Institute for Molecular Medicine Finland FIMM, University of Helsinki, with their collaborators have shown that first Tamiflu resistant pandemic influenza pH1N1 viruses have emerged in Finland. Furthermore, they have identified a novel antiviral agent MK2206 and shown that the pH1N1 viruses are not able to develop resistance against it.

In 2009 the influenza pH1N1 virus caused the first flu pandemic in the 21st century. The virus reached Finland in May 2009 and killed more than 50 people in the country. Since 2011 the pH1N1 virus infects Finns mainly during flu epidemics (winter/spring seasons).

Infections with influenza pH1N1 virus vary from asymptomatic to serious complicated illnesses. World Health Organization has recommended Tamiflu for treatment of patients with severe or progressive illness. The disadvantage of this drug is that it targets viral proteins which mutate quickly and the virus develops resistance to it.

The Medical Systems Virology group at FIMM, together with collaborators has recently sequenced genomes of 135 pH1N1 influenza strains isolated from Finnish patients in 2009-2013 and found one Tamiflu-resistant strain from the 2012-2013 epidemic season. The study was published in the Genome Announcements journal and is now available online.

"This finding suggests that there could be more resistant strains in upcoming seasons. Therefore, there is a need for the development of new antiviral agents against pH1N1," says Dr. Triin Lakspere.

In another study published this week the group investigated influenza pH1N1 virus-host cell interaction in detail and found that certain host function could be temporally inhibited with small molecule MK2206 to block influenza infection in cell culture.

"Importantly, the virus was unable to acquire resistance to host-directed MK2206 in contrast to virus-directed Tamiflu. This small molecule is in clinical trials against cancer and has high specificity and good pharmacological properties, which could warrant its further development as antiviral drug for treatment of pH1N1 virus infection," Dr. Oxana Denisova says.


Story Source:

The above story is based on materials provided by Helsingin yliopisto (University of Helsinki). Note: Materials may be edited for content and length.


Journal Reference:

  1. T. Lakspere, J. Tynell, M. Kaloinen, M. Vanlede, A. Parsons, N. Ikonen, H. Kallio-Kokko, A. Kantele, P. Mattila, H. Almusa, I. Julkunen, D. Kainov, L. Kakkola. Full-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Finnish Patients from 2009 to 2013. Genome Announcements, 2014; 2 (1): e01004-13 DOI: 10.1128/genomeA.01004-13

Cite This Page:

Helsingin yliopisto (University of Helsinki). "Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered." ScienceDaily. ScienceDaily, 24 April 2014. <www.sciencedaily.com/releases/2014/04/140424102307.htm>.
Helsingin yliopisto (University of Helsinki). (2014, April 24). Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2014/04/140424102307.htm
Helsingin yliopisto (University of Helsinki). "Novel therapeutic agent for Tamiflu-resistant pH1N1 influenza virus discovered." ScienceDaily. www.sciencedaily.com/releases/2014/04/140424102307.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins